You are not logged in!
Do you want to login? It's free!

Thu, 26 March 2015.
Check the latest stories & news.

ALERT

After nearly seven years of providing public data, we have decided to shut down the www.implu.com website. Our final day of operation will be March 31, 2015. Thank you for using www.implu.com!

Search implu: Advanced

Who do you implu?    Create a Free Account!

Patent Applications

Pub DatePub NumberApp NumberApp DateTitle
2011-02-0320110023242126796572008-09-23DICHROMOPHORE CARBONYL OR HETEROCYCLIC DYE, DYE COMPOSITION COMPRISING THIS DYE, PROCESS FOR DYEING KERATIN MATERIALS USING THIS DYE
2011-02-0320110024929129354302009-03-30APPARATUS FOR PRODUCING LIPOSOMES AND METHOD OF PRODUCING LIPOSOMES
2011-02-0320110027171124434962007-10-05PH SENSITIVE LIPOSOME COMPOSITION
2011-02-0320110027172127470402008-12-10DRUG DELIVERY SYSTEM FOR PHARMACEUTICALS AND RADIATION
2011-02-0320110027173128100952008-12-24EPHRIN TYPE-A RECEPTOR 10 PROTEIN
2011-02-0320110027174129058582010-10-15NANOTUBES FOR CANCER THERAPY AND DIAGNOSTICS
2011-02-0320110027175122808292007-02-27CANCER IMAGING AND TREATMENT
2011-02-0320110027176128440182010-07-27HOMING PEPTIDE FOR TUMOR VASCULATURE
2011-02-0320110027177129336382008-09-17INHIBITION OF ANGIOGENESIS
2011-02-0320110027178128679142009-02-26IMAGING THE CENTRAL NERVOUS SYSTEM
2011-02-0320110027179129044332010-10-14Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
2011-02-0320110027180127593222010-04-13DETECTION AND TREATMENT OF PROSTATE CANCER
2011-02-0320110027181128021482010-05-28Device including altered microorganisms, and methods and systems of use
2011-02-0320110027182128285792010-07-01SUBSTANCE FOR OBTAINING HIGHLY EFFECTIVE TUMOR MEDICATIONS AS WELL AS A PROCESS
2011-02-0320110027183128641972009-01-26Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver
2011-02-0320110027184121608892007-01-12PROTEIN C PATHWAY ASSOCIATED POLYMORPHISMS AS RESPONSE PREDICTORS TO ACTIVATED PROTEIN C OR PROTEIN C-LIKE COMPOUND ADMINISTRATION
2011-02-0320110027185126676252008-07-14Methods of Screening for Anti-Angiogenic Compounds
2011-02-0320110027186126809822008-10-06TAZ/WWTR1 FOR DIAGNOSIS AND TREATMENT OF CANCER
2011-02-0320110027187127348642008-11-21THERAPEUTIC OR PROPHYLACTIC AGENT, DETECTION METHOD AND DETECTION AGENT FOR METABOLIC SYNDROME, AND METHOD FOR SCREENING OF CANDIDATE COMPOUND FOR THERAPEUTIC AGENT FOR METABOLIC SYNDROME
2011-02-0320110027188129014022010-10-08Methods, Compositions and Devices for Treating Lesioned Sites Using Bioabsorbable Carriers
2011-02-0320110027190125997132008-06-04COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL
2011-02-0320110027192129207072009-03-09SLIM-FIT FAT BURNING WATER
2011-02-0320110027193129031202010-10-12COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS
2011-02-0320110027194129034712010-10-13HYPOCHLORITE DENTURE COMPOSITIONS AND METHODS OF USE
2011-02-0320110027195125815292009-10-19COMPOSITION FOR DENTAL BARRIER COMPRISING AT LEAST ONE MONOMER, AT LEAST ONE POLYMERIZATION INITIATING SYSTEM, AND AT LEAST ONE INDICATOR ENABLING THE POLYMERIZATION REACTION TO BE MONITORED
2011-02-0320110027196125346212009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027197125346492009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027198125346822009-08-03TOOTH SENSITIVITY TREATMENT COMPOSITIONS
2011-02-0320110027199128029552010-06-17Drink container with a breath strip
2011-02-0320110027200128471772010-07-30METHODS TO STABILIZE AND PREVENT BREAKDOWN OF SUNSCREEN AND OTHER TOPICAL AND ORAL PREPARATIONS AND COMPOSITIONS PRODUCED THEREBY
2011-02-0320110027201129019112010-10-11METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
2011-02-0320110027202128088392008-11-12FLUID OIL-IN-WATER SUNSCREEN EMULSIONS CONTAINING GEMINI SURFACTANTS AND A CROSSLINKED COPOLYMER OF METHACRYLIC ACID AND OF C1-C4 ALKYL ACRYLATE
2011-02-0320110027203129019682010-10-11SYNTHESIS OF A NITROXIDE ANTIOXIDANT AND METHODS OF USE IN COSMETIC AND DERMATOLOGICAL COMPOSITIONS
2011-02-0320110027204129029722010-10-12ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
2011-02-0320110027205129374832009-04-16USE OF MYRTLE EXTRACT AS DEPIGMENTING AGENT
2011-02-0320110027206124383682009-01-22Alkyl Quaternium Silicone Compounds
2011-02-0320110027207125103292009-07-28EYELASH AND EYEBROW FORTIFIER
2011-02-0320110027208128907962010-09-27Photolabile Fragrance Storage Substances
2011-02-0320110027209129367612009-04-08Compositions Containing Cyclic Peptides And Methods Of Use
2011-02-0320110027210128669712009-01-22TWO-PART COSMETIC PRODUCT WITH SWELLING EFFECT TO BIOLOGICAL SURFACES
2011-02-0320110027211129348492009-03-13HAIR STYLING COMPOSITION
2011-02-0320110027213128446472010-07-27ORGANOPOLYSILOXANE HAVING AMIDE GROUP, AND COSMETIC MATERIAL CONTAINING SAME
2011-02-0320110027214126932612010-01-25POLYQUATERNIUM- 1 SYNTHESIS METHODS
2011-02-0320110027215129042302010-10-14PROTEIN-BASED POLYMER TISSUE ADHESIVES FOR MEDICAL USE
2011-02-0320110027216129042252010-10-14PROTEIN-BASED POLYMER TISSUE ADHESIVES FOR MEDICAL USE
2011-02-0320110027217127882662010-05-26IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
2011-02-0320110027218124394862007-08-28TNF SUPERFAMILY FUSION PROTEINS
2011-02-0320110027219128047952010-07-29Treatment of Crohn's disease with laquinimod
2011-02-0320110027220119927312006-09-28Interleukin-1 Conjugates and Uses Thereof
2011-02-0320110027221125299812008-09-24Skincare Composition Comprising HSA Fusion Protein, Preparation Method And Uses Thereof
2011-02-0320110027222126778992008-09-24Vaccine for the Treatment of Osteoarthritis
2011-02-0320110027223127389492008-10-29USE OF ELECTROPHILIC COMPOUNDS FOR INDUCING PLATELET PRODUCTION OR MAINTAINING PLATELET FUNCTION
2011-02-0320110027224128878432010-09-22USE OF A CYTOKINE FROM THE INTERLEUKIN-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR COMBINED ADMINISTRATION WITH INTERFERON-ALPHA
2011-02-0320110027225129002822010-10-07MN/CA IX and EGFR Pathway Inhibition
2011-02-0320110027226126741192007-08-22INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5)
2011-02-0320110027227127353922009-01-14ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVIRUS INFECTION
2011-02-0320110027228129051492010-10-15USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE
2011-02-0320110027229128488562010-08-02CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-ALPHA TO HEPATITIS C INFECTED PATIENTS
2011-02-0320110027230128674342009-02-20COMPOSITIONS COMPRISING PHYTOESTROGENES SELECTIVE FOR ESTROGEN BETA RECEPTOR AND DIETARY FIBRES
2011-02-0320110027231125207892007-12-18METHOD FOR THE RANDOM DIVERSIFICATION OF A GENETIC SEQUENCE WHILE PRESERVING THE IDENTITY OF SOME INNER SEGMENTS OF SAID GENETIC SEQUENCE
2011-02-0320110027234124507642008-04-10METHODS FOR IDENTIFICATION AND SELECTION OF HUMAN EMBRYONIC STEM CELL DERIVED CELLS
2011-02-0320110027235127987492010-04-08Targeted integration into stem cells
2011-02-0320110027236128677192009-02-16PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOARTICULAR DISEASES
2011-02-0320110027237129054362010-10-15Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
2011-02-0320110027238129081192010-10-20Mesenchymal Stem Cells and Uses Therefor
2011-02-0320110027239125119402009-07-29ADIPOSE-DERIVED STROMAL CELLS (ASC) AS DELIVERY TOOL FOR TREATMENT OF CANCER
2011-02-0320110027240128119322009-01-09SECRETABLE HIV ENTRY INHIBITORY PEPTIDES FOR THERAPY OF HIV INFECTION
2011-02-0320110027241129052532010-10-15Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
2011-02-0320110027242129348432009-03-27METHOD FOR PRODUCTION OF TRANSFECTED CELL
2011-02-0320110027243127454412008-12-03COMPOSITION BASED ON PROBIOTIC BACTERIA IN ASSOCIATION WITH A PREBIOTIC AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES AND/OR INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY
2011-02-0320110027244128445162010-07-27Compositions and methods of preparing alloreactive cytotoxic T cells
2011-02-0320110027245128446682010-07-27Pairing processes for preparing alloreactive cytotoxic T cells
2011-02-0320110027246125644782009-09-22NOVEL BACILLUS THURINGIENSIS STRAIN FOR INHIBITING INSECT PESTS
2011-02-0320110027247127780942010-05-11METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)
2011-02-0320110027248128099692008-12-26Sugar Chain-Related Gene and Use Thereof
2011-02-0320110027249127846752010-05-21Fusion of Peptidoglycan Hydrolase Enzymes to a Protein Transduction Domain Allows Eradication of both Extracellular and Intracellular Gram Positive Pathogens
2011-02-0320110027250128459492010-07-29Sealants for Fetal Membrane Repair
2011-02-0320110027251129219332009-03-06NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
2011-02-0320110027253126685172008-07-09PADLOCK PROBE AMPLIFICATION METHODS
2011-02-0320110027254128456532010-07-28COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE
2011-02-0320110027255129051352010-10-15Composition and Method for Treating Papilloma Virus and Equine Sarcoids
2011-02-0320110027256128629482010-08-25FUSION PROTEINS
2011-02-0320110027257127442002009-01-07CLOTTABLE CONCENTRATE OF PLATELET GROWTH FACTORS AND PREPARATION METHOD THEREOF
2011-02-0320110027258128775532010-09-08MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES
2011-02-0320110027259129029942010-10-12COMPONENT OF BROMELAIN
2011-02-0320110027260126467472009-12-23BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
2011-02-0320110027261128721722010-08-31ANTI-HEPCIDIN ANTIBODIES AND USES THEREOF
2011-02-0320110027262128799162010-09-10PLATFORM ANTIBODY COMPOSITIONS
2011-02-0320110027263128997002010-10-07SOLUBLE INTERLEUKIN-20 RECEPTOR
2011-02-0320110027264129195742009-02-26GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
2011-02-0320110027265126755972008-08-29Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions
2011-02-0320110027266126757992008-08-27Humanized anti-CXCR5 antibodies, derivatives thereof and their use
2011-02-0320110027267127417022008-11-10Fusion Proteins of Mannose Binding Lectins for Treatment of Disease
2011-02-0320110027268127448492008-11-19ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF
2011-02-0320110027269127452292008-11-2614-3-3 Antagonists for the Prevention and Treatment of Arthritis
2011-02-0320110027270127881032010-05-26MONOCLONAL ANTIBODIES AGAINST INFLUENZA VIRUS GENERATED BY CYCLICAL ADMINISTRATION AND USES THEREOF
2011-02-0320110027271128169182010-06-16ANTIBODY COMPOSITION EXHIBITING CELLULAR CYTOTOXICTY DUE TO GLYCOSYLATION
2011-02-0320110027272128170972010-06-16STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS
2011-02-0320110027273128218162010-06-23IMMUNOTHERAPY OF AUTOIMMUNE DISORDERS
2011-02-0320110027274128464932010-07-29ANTIPROLIFERATIVE COMPOUNDS, CONJUGATES THEREOF, METHODS THEREFOR, AND USES THEREOF
2011-02-0320110027275128471632010-07-30INHIBITION OF TUMOR METASTASIS
2011-02-0320110027276128640752009-01-21Optimized CD40 Antibodies and Methods of Using the Same
2011-02-0320110027277129358122009-03-31PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORS
2011-02-0320110027278127323712010-03-26REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF
2011-02-0320110027279126910462010-01-21RECOMBINANT ANTIBODIES SPECIFIC FOR BETA-AMYLOID ENDS, DNA ENCODING AND METHODS OF USE THEREOF
2011-02-0320110027280128375882010-07-16Methods For Inducing Autolysis In Infectious Bacteria
2011-02-0320110027281129055892010-10-15SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
2011-02-0320110027282123104322007-08-23INTERFERON ANTAGONISTS, ANTIBODIES THERETO AND ASSOCIATED METHODS OF USE
2011-02-0320110027283126768172008-09-05METHODS FOR DIAGNOSING AND TREATING CANCERS
2011-02-0320110027284127407772008-10-27NOGO-A BINDING MOLECULES AND PHARMACEUTICAL USE THEREOF
2011-02-0320110027285127546262010-04-06METHODS AND AGENTS MODULATING UPA/UPAR ACTIVITY
2011-02-0320110027286128439052010-07-27High Affinity Human Antibodies to Human Angiopoietin-2
2011-02-0320110027287129030842010-10-12ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
2011-02-0320110027288129347732009-03-24HUMAN MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN, AND THEIR USE AS THERAPEUTIC AGENTS
2011-02-0320110027289127695992010-04-28METHOD FOR TREATING SYNOVIAL SARCOMA
2011-02-0320110027290129088922010-10-21ANTI-IL-17 ANTIBODIES
2011-02-0320110027291127075212010-02-17METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE
2011-02-0320110027292128399332010-07-20Protein Formulations with Reduced Viscosity and Uses Thereof
2011-02-0320110027293126447992009-12-22METHODS AND COMPOSITIONS FOR THE INHIBITION OF VIRAL INFECTION BY TARGETING INTRACELLULAR TRAFFICKING
2011-02-0320110027294129009242010-10-08Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
2011-02-0320110027295126767412008-09-08Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses
2011-02-0320110027296129358382009-04-08ANTIBODIES FOR TREATING CANCER
2011-02-0320110027297129371782009-03-30Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing
2011-02-0320110027298128437392010-07-26MICROBIAL DELIVERY SYSTEM
2011-02-0320110027299128517292010-08-06MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS
2011-02-0320110027300128670562009-02-13Identification of a novel cysteine-rich cell penetrating peptide
2011-02-0320110027301128870322010-09-21EX-VIVO PRIMING FOR GENERATING CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR NON-TUMOR ANTIGENS TO TREAT AUTOIMMUNE AND ALLERGIC DISEASE
2011-02-0320110027302129039612010-10-13PEPTIDE VACCINES FOR LUNG CANCERS EXPRESSING TTK, URLC10 OR KOC1 POLYPEPTIDES
2011-02-0320110027303129357612009-03-31PARTIAL PEPTIDE OF SURVIVIN PRESENTED ON MHC CLASS II MOLECULE AND USE THEROF
2011-02-0320110027304126682582008-07-11YERSINIA PESTIS ANTIGENS, VACCINE COMPOSITIONS AND RELATED METHODS
2011-02-0320110027305128485682010-08-02Composition Comprising an Extract of Herbal Combination Thereof for Preventing and Treating Diabetes Mellitus
2011-02-0320110027306128310172010-07-06TC-83-Derived Alphavirus Vectors, Particles and Methods
2011-02-0320110027307127853122010-05-21ANTI-SEPSIS CONJUGATE VACCINE
2011-02-0320110027308126760792008-09-09COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES
2011-02-0320110027309124418512007-09-18COMPOSITIONS AND METHODS OF ENHANCING IMMUNE RESPONSES
2011-02-0320110027310125988742008-05-05Compositions and Methods for Cancer Treatment
2011-02-0320110027311128440442010-07-27COMBINATION OF PROTEIN VACCINE AND MESENCHYMAL STEM CELLS FOR TREATING CANCER
2011-02-0320110027312129371812009-04-08CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF
2011-02-0320110027313129361652009-04-06VIRAL RECOMBINEERING AND USES THEREOF
2011-02-0320110027314122232082007-01-26Influenza Vaccines Containing Hemagglutinin and Matrix Proteins
2011-02-0320110027315126767972008-09-05PROTEIN CAGES AND THEIR USES
2011-02-0320110027316127441362008-11-21BLUETONGUE VIRUS VACCINE AND IMMUNOGENIC COMPOSITIONS, METHODS OF USE AND METHODS OF PRODUCING SAME
2011-02-0320110027317128042422010-07-16Production of poliovirus at high titers for vaccine production
2011-02-0320110027318124100832009-03-24NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS
2011-02-0320110027319127834912010-05-19METHODS OF ELICITING OR BOOSTING A CELLULAR IMMUNE RESPONSE
2011-02-0320110027321126014312008-05-23Chlamydia Vaccine Comprising HtrA Polypeptides
2011-02-0320110027322125455602009-08-21TUMOR VACCINE, A METHOD FOR PRODUCING A TUMOR VACCINE AND A METHOD FOR CARRYING OUT ANTITUMOR IMMUNOTHERAPY
2011-02-0320110027323128504282010-08-04ADJUVANTS AND METHODS OF USE
2011-02-0320110027324127470962007-12-10O-DESMETHYL-VENLAFAXINE FOR TREATING MAJOR DEPRESSIVE DISORDER
2011-02-0320110027325129348192009-03-09ORALLY-ADMINISTERED AGENT
2011-02-0320110027326129354972009-03-26External Composition for Skin
2011-02-0320110027327126739192008-10-01COSMETIC OR PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
2011-02-0320110027328128468622010-07-30Oral Care Articles and Methods
2011-02-0320110027329127845972010-05-21Single-use, Disposable Strip For Application Of Topical Compositions
2011-02-0320110027331125115242009-07-29AN IMPLANTABLE DRUG DEPOT HAVING A REVERSIBLE PHASE TRANSITION MATERIAL FOR TREATMENT OF PAIN AND/OR INFLAMMATION
2011-02-0320110027335126728442008-08-11COATED MEDICAL DEVICES
2011-02-0320110027338129002162010-10-07BIOLOGIC REPLACEMENT FOR FIBRIN CLOT
2011-02-0320110027340125338582009-07-31IMPLANTABLE DRUG DEPOT FOR WEIGHT CONTROL
2011-02-0320110027342128455552010-07-28S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY
2011-02-0320110027344126481072009-12-28Alginate-Containing Wound Dressing, Method and Apparatus for Making the Same
2011-02-0320110027345126679152008-07-03COMPOSITION CONTAINING ROTIGOTINE AND USE THEREOF AND TRANSDERMAL PATCH CONTAINING THE COMPOSITION
2011-02-0320110027346123030882007-05-29Lyase Enzymes, Nucleic Acids Encoding Them and Methods for Making and Using Them
2011-02-0320110027347125105412009-07-28POLYMERSOMES AND METHODS OF MAKING AND USING THEREOF
2011-02-0320110027348126755042007-08-27COMPOSITION AND METHOD INHIBITING INFLAMMATION
2011-02-0320110027349128125412009-01-12POLYPEPTIDE VACCINE AND VACCINATION STRATEGY AGAINST MYCOBACTERIUM
2011-02-0320110027350128432842010-07-26GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS
2011-02-0320110027351129032662010-10-13LIPOSOMAL FORMULATIONS COMPRISING AN AMPHIPATHIC WEAK BASE LIKE TEMPAMINE FOR TREATMENT OF NEURODEGENERATIVE CONDITIONS
2011-02-0320110027352128633802009-01-16COMPOUNDS FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN
2011-02-0320110027353129025942010-10-12Therapeutic Delivery System
2011-02-0320110027354129356732009-03-31ANTI-PARKINSONIAN COMPOUNDS
2011-02-0320110027355129365782009-04-07HIGH-FLUIDITY AND NON-CAKING PULVERULENT CRYSTALLINE MALTITOL COMPOSITION
2011-02-0320110027356128643972009-01-26Combination of Oral Medicaments Bonded by a Wrapping
2011-02-0320110027357129005992010-10-08Compositions and methods for timed release of water-soluble nutritional supplements
2011-02-0320110027358125325352008-03-31VALSARTAN TABLET FORMULATIONS
2011-02-0320110027359127207682010-03-10Novel Pharmaceutical Compositions Comprising Levetiracetam
2011-02-0320110027360128456002010-07-28PHARMACOKINETICS OF S-ADENOSYLMETHIONINE FORMULATIONS
2011-02-0320110027361128658012009-02-03EXTENDED RELEASE DOSAGE FORM OF PALIPERIDONE
2011-02-0320110027362128669992009-02-10TABLET HAVING IMPROVED ELUTION PROPERTIES
2011-02-0320110027363125914472009-11-19Nouvelle forme d'administration de proteines osteogeniques
2011-02-0320110027364127448482008-11-26BIOACTIVE AND RESORBABLE SOYBEAN-BASED BIOMATERIALS
2011-02-0320110027365128311902010-07-06Patch Formulation For External Use
2011-02-0320110027366129027102010-10-12SKIN EQUIVALENT CULTURE
2011-02-0320110027367129029312010-10-12ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
2011-02-0320110027368129051862010-10-15POLYMERIC COMPOSITIONS COMPRISING THERAPEUTIC AGENTS IN CRYSTALLINE PHASES, AND METHODS OF FORMING THE SAME
2011-02-0320110027369128588832010-08-18PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS
2011-02-0320110027370129055672010-10-15Sustained Drug Release Composition
2011-02-0320110027371113677162006-03-06Nanoparticulate statin formulations and novel statin combinations
2011-02-0320110027372129020332010-10-11MULTIPARTICULATES COMPRISING LOW-SOLUBILITY DRUGS AND CARRIERS THAT RESULT IN RAPID DRUG RELEASE
2011-02-0320110027373125262392008-02-07METHODS AND COMPOSITIONS FOR MODULATING SIALIC ACID PRODUCTION AND TREATING HEREDITARY INCLUSION BODY MYOPATHY
2011-02-0320110027374126199182009-11-17CAPECITABINE RAPIDLY DISINTEGRATING TABLETS
2011-02-0320110027375127381912008-10-14USE OF LANTHANIDE-BASED NANOPARTICLES AS RADIOSENSITIZING AGENTS
2011-02-0320110027376127476392008-12-02Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds
2011-02-0320110027377128157152010-06-15IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM
2011-02-0320110027378129020172010-10-11PROCESS OF MAKING FLOWABLE HEMOSTATIC COMPOSITIONS AND DEVICES CONTAINING SUCH COMPOSITIONS
2011-02-0320110027379127465002008-12-04Oligo-Ethylene Glycol-Based Polymer Compositions and Methods of Use
2011-02-0320110027381124456352007-10-16TREATMENT OF OSTEOPOROSIS
2011-02-0320110027382128035432010-06-29Solubilized benzoyl peroxyde acne
2011-02-0320110027384129361262009-04-06PHOTOSENSITISING COMPOSITION AND ITS USES
2011-02-0320110027385127442252008-11-21NANO-PARTICLE DISPERSIONS
2011-02-0320110027387126607222010-03-03Nutritional supplement for use with poultry and livestock and method of using
2011-02-0320110027388128473422010-07-30Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus
2011-02-0320110027389128126702009-01-13Low Viscosity Liquid Polymeric Delivery System
2011-02-0320110027390129039342010-10-13Methods for Reducing Cisplatin Nephrotoxicity
2011-02-0320110027391128094182008-03-04LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT
2011-02-0320110027393125975482008-04-30HUMAN DIABETES SUSCEPTIBILITY EEFSEC GENE
2011-02-0320110027394128091852008-12-22Cross-Linked Biopolymers, Related Compounds and Methods of Use
2011-02-0320110027396128101782008-12-23NOVEL MILK THISTLE EXTRACT, METHOD FOR THE PRODUCTION, AND USE
2011-02-0320110027397125345712009-08-03METHODS OF TREATING AUTISM SPECTRUM DISORDERS AND COMPOSITIONS FOR SAME
2011-02-0320110027398126740442008-08-19METHODS OF MAKING OLIVE JUICE EXTRACTS CONTAINING REDUCED SOLIDS
2011-02-0320110027399129354732009-03-31Antiviral Agent and Antiviral Composition
2011-02-0320110027455127665092010-04-23SEQUESTERING SUBUNIT AND RELATED COMPOSITIONS AND METHODS
2011-02-0320110028367129034182010-10-13PHOTO-LABILE PRO-FRAGRANCE CONJUGATES
2011-02-0320110028368129043092010-10-14HYPOCHLORITE DENTURE COMPOSITIONS AND METHODS OF USE
2011-02-0320110028382127433632008-10-07TREATMENT OF ORAL PHARYNGEAL DYSPHAGIA
2011-02-0320110028383127891482010-05-27Activated Forms Of Notch And Methods Based Thereon
2011-02-0320110028385128663252009-01-27Combination of Immunomodulator and Anti-Pathogenic Agent
2011-02-0320110028387127550462010-04-06METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
2011-02-0320110028388129361642008-04-03DOUBLE-STRANDED POLYETHYLENE GLYCOL MODIFIED GROWTH HORMONE, PREPARATION METHOD AND APPLICATION THEREOF
2011-02-0320110028389129010482010-10-08USE OF INFANT FORMULA WITH REDUCED PROTEIN CONTENT
2011-02-0320110028390129343752009-05-18Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors
2011-02-0320110028391129053242010-10-15Use of GLP-1 Peptides
2011-02-0320110028392129011782010-10-08METHODS FOR USE OF BRANCHED AMINO ACIDS
2011-02-0320110028393125126512009-07-30FLOWABLE PASTE AND PUTTY BONE VOID FILLER
2011-02-0320110028394128467242010-07-29THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
2011-02-0320110028395125220422008-01-03PEPTIDE MODULATORS OF ANGIOGENESIS AND USE THEREOF
2011-02-0320110028396129355512009-03-30MEDICAL COMPOSITION
2011-02-0320110028397127451652008-12-01Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders
2011-02-0320110028398123058852007-07-10METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS
2011-02-0320110028399129880762009-04-15CITRULLINATED CYTOKINES
2011-02-0320110028400129358182009-03-26SULFATED UNSATURATED DISACCHARIDIC CHONDROITIN SULFATE IN CONNECTIVE TISSUE PROTECTION AND REPAIR
2011-02-0320110028401128454602010-07-28CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF
2011-02-0320110028402128201282010-06-21SUBSTANCE P-SAPORIN (SP-SAP) CONJUGATES AND METHODS OF USE
2011-02-0320110028403127233882010-03-12HSP70-Based Treatment for Autoimmune Diseases and Cancer
2011-02-0320110028404129360552009-03-19Composition Comprising Vegetable Peptone for Promoting Stem Cell Proliferation
2011-02-0320110028405128095852008-12-17SULFAMIDES AS ZAP-70 INHIBITORS
2011-02-0320110028406129038592010-10-13Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant
2011-02-0320110028407125263252008-02-08ENHANCEMENT OF INNATE RESISTANCE TO INFECTION
2011-02-0320110028408127408052008-10-31 DIAGNOSTIC MOLECULE AND THERAPEUTIC TARGET
2011-02-0320110028409128421972010-07-23DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES
2011-02-0320110028410117549172007-05-29Use of Amygdalin Analogues for the Treatment of Psoriasis
2011-02-0320110028411124464312007-10-18ALPHA-GALACTOCERAMIDE ANALOGS, THEIR METHODS OF MANUFACTURE, INTERMEDIATE COMPOUNDS USEFUL IN THESE METHODS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
2011-02-0320110028412128049722010-08-03Herbal enhanced analgesic formulations
2011-02-0320110028413129039502010-10-13Methods of Reducing Methotrexate Nephrotoxicity
2011-02-0320110028414129365392009-03-17GLUCOPYRANOSIDE DERIVATIVES
2011-02-0320110028415127466302008-12-04USE OF 3-(INDOLYL)- OR 3-(AZAINDOLYL)-4-ARYLMALEIMIDE DERIVATIVES IN LEUKENIA MANAGEMENT
2011-02-0320110028416129191572008-02-25NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH COMPRISING EXTRACTS OF FOR EXAMPLE ROSEMARY OR CARAWAY
2011-02-0320110028417128477402010-07-30Macrocyclic Compounds and Methods of Use Thereof
2011-02-0320110028418129220442009-03-12USE OF GABBA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS
2011-02-0320110028420129367332009-04-07Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors
2011-02-0320110028421127982672010-03-31Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
2011-02-0320110028422128098052008-12-18COMBINATION OF NILOTINIB AND A NITROGEN MUSTARD ANALOGUE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
2011-02-0320110028424128440112010-07-27OIL-IN-WATER MICROEMULSION CARRYING LARGE AMOUNT OF OIL
2011-02-0320110028425129359182009-04-09Vesicle And Cosmetic Containing The Same
2011-02-0320110028426125104782009-07-28DEWATERING BIOMASS MATERIAL COMPRISING POLYSACCHARIDE, METHOD FOR EXTRACTING POLYSACCHARIDE FROM BIOMASS MATERIAL, AND DEWATERED BIOMASS MATERIAL
2011-02-0320110028427127461062008-12-04DIETARY FIBER AND METHOD FOR PREPARING DIETARY FIBER
2011-02-0320110028428127506552010-03-30HIRSUTELLA SINENSIS MYCELIA COMPOSITIONS AND METHODS FOR TREATING SEPSIS AND RELATED INFLAMMATORY RESPONSES
2011-02-0320110028429127506272010-03-30COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA
2011-02-0320110028430128764742010-09-07INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND
2011-02-0320110028431128368102010-07-15ORAL MUCOADHESIVE DOSAGE FORM
2011-02-0320110028432128462412010-07-29USE OF CYCLODEXTRIN FOR TREATMENT AND PREVENTION OF BRONCHIAL INFLAMMATORY DISEASES
2011-02-0320110028433129347332009-03-26QUINAZOLINONE DERIVATIVES AS TUBULIN POLYMERIZATION INHIBITORS
2011-02-0320110028435128475682010-07-30CRYSTALLIZATION METHOD AND BIOAVAILABILITY
2011-02-0320110028436129334192009-03-19ORAL COMBINATION OF VITAMINS
2011-02-0320110028437128562912010-08-13PHOSPHORYLATED PYRONE ANALOGS AND METHODS
2011-02-0320110028438127347852008-12-03MEDICAL USE OF 3-2,2,2-TRIMETHYLHYDRAZINIUM PROPIONATE SALTS.
2011-02-0320110028439128043412010-07-20Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer
2011-02-0320110028440129358772009-03-26Simultaneous Method for the Preparation of a Mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
2011-02-0320110028441127384122008-10-13NOVEL PHENYL-SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES
2011-02-0320110028442129191342009-02-27DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
2011-02-0320110028444129360882009-04-02PHARMACEUTICALLY ACCEPTABLE SALTS OF ANTI-INFECTION QUINOLONE COMPOUNDS
2011-02-0320110028445128661252009-02-10Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
2011-02-0320110028446129005422010-10-08ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS
2011-02-0320110028447129189142009-02-26INDAZOLE DERIVATIVES
2011-02-0320110028448129205692009-03-03PYRIDINE COMPOUNDS
2011-02-0320110028449129205742009-03-03NOVEL AMINOMETHYL BENZENE DERIVATIVES
2011-02-0320110028450128440072010-07-27Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines
2011-02-0320110028451128458132010-07-29Dihydrobenzoindazoles
2011-02-0320110028452128945252010-09-30PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS
2011-02-0320110028453128439612010-07-27Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1
2011-02-0320110028454127956452010-06-07DEUTERIUM-ENRICHED BAZEDOXIFENE
2011-02-0320110028455127468552008-12-12Indole-substituted 3-cyanopyridines As Kinase Inhibitors
2011-02-0320110028456128124322009-01-12Solid Pharmaceutical Dosage Form
2011-02-0320110028457129362222009-04-01PHARMACEUTICAL PREPARATION COMPRISING PERMETHYLATED CYCLODEXTRIN
2011-02-0320110028458129371012009-04-09INHIBITION OF CELL MIGRATION BY A FARNESYLATED DIBENZODIAZEPINONE
2011-02-0320110028459128993652010-10-06Wound Healing
2011-02-0320110028460128487922010-08-02TOPICAL FORMULATION
2011-02-0320110028461129362752009-03-23HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
2011-02-0320110028462119920692006-09-15Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment
2011-02-0320110028463126674922008-07-02AMIDE COMPOUNDS
2011-02-0320110028464127431382008-11-03INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
2011-02-0320110028465128119722009-01-09AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME
2011-02-0320110028466128474592010-07-30NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES
2011-02-0320110028467129354782009-03-31HETEROCYCLIC DERIVATIVES
2011-02-0320110028468129366932009-04-20COMPOUNDS HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
2011-02-0320110028469126807632008-09-24Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor
2011-02-0320110028470126740182008-07-31Detection and Treatment of Schizophrenia
2011-02-0320110028471129186502009-02-20COMBINATION THERAPY 238
2011-02-0320110028472129370312009-03-23THIENOPYRIMIDINES
2011-02-0320110028473128337332010-07-09METHODS OF TREATING DRUG RESISTANT AND OTHER TUMORS BY ADMINISTERING 6,7-DIALKOXY QUINAZOLINE DERIVATIVES
2011-02-0320110028474128540942010-08-10PROTEIN KINASE AND PHOSPHATASE INHIBITORS
2011-02-0320110028475129010632010-10-08TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS
2011-02-0320110028476128739712010-09-01PROTON PUMP INHIBITORS
2011-02-0320110028477129366402008-11-07STABLE OPHTHALMIC FORMULATIONS
2011-02-0320110028478127826502010-05-18ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
2011-02-0320110028479127406802008-10-16SUBSTITUTED PYRROLOTRIAZINES AND THEIR USE
2011-02-0320110028480129357962008-04-01ORODISPERSABLE FORMULATIONS OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITORS
2011-02-0320110028481129362212009-04-02HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
2011-02-0320110028482127826552010-05-18ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE
2011-02-0320110028483128576172010-08-17INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, AND 1,2-BENZISOTHIAZOLES, AND PREPARATION AND USES THEREOF
2011-02-0320110028484129366642009-04-092-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
2011-02-0320110028485128834282010-09-161,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS
2011-02-0320110028486129364312009-04-16INDOLES AS MODULATORS OF NICOTICIC ACETYLCHOLINE RECEPTOR SUBTYPE ALPHA-7
2011-02-0320110028487127340422009-07-02IMIDAZOPYRIMIDINES AND USES THEREOF
2011-02-0320110028488127149972010-03-01COMBINATION PRODUCT COMPRISING SRC KINASE INHIBITOR AZDO530 AND AN ANTIOESTROGEN OR EGFR-TK-INHIBITOR
2011-02-0320110028489128568792010-08-16Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders
2011-02-0320110028490128122722009-01-214-PHENYL-PIPERAZIN-1-YL-ALKYL-BENZOIMIDAZOL-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE IN-HIBITORS
2011-02-0320110028491128643952009-01-23APOPTOSIS INHIBITOR
2011-02-0320110028492128434942010-07-26Heteroaryl Compounds and Their Uses
2011-02-0320110028493129362912009-04-03HETEROCYCLIC DERIVATIVE AND USE THEREOF
2011-02-0320110028494119898862006-07-28HCV NS3 Protease Inhibitors
2011-02-0320110028495128095722008-12-11THE USE OF 6-HALOGENO-[1,2,4]-TRIAZOLO-[1,5-a]-PYRIMIDINE COMPOUNDS FOR COMBATING PESTS IN AND ON ANIMALS
2011-02-0320110028496128049702010-08-03Deuterium-enriched pyrimidine compounds and derivatives
2011-02-0320110028497124504772008-03-30NOVEL DERIVATIVES OF PURINIC AND PYRIMIDINIC ANTIVIRAL AGENTS AND USE THEREOF AS POTENT ANTICANCER AGENTS
2011-02-0320110028498124383062007-09-06METHOD FOR EVALUATING PATIENTS FOR TREATMENT WITH DRUGS TARGETING RET RECEPTOR TYROSINE KINASE
2011-02-0320110028499128954722010-09-30PHARMACEUTICAL COMBINATION COMPRISING VITAMIN K
2011-02-0320110028501129363132009-03-26SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
2011-02-0320110028502128471292010-07-30DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS
2011-02-0320110028503128456552010-07-28COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
2011-02-0320110028504119894682006-07-28Formulation of radioprotective alpha beta unsaturated aryl sulfones
2011-02-0320110028505129031312010-10-12COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS
2011-02-0320110028506126667852008-06-30Pharmaceutical Composition For Preventintion And Treatment Of Restenosis Comprising Isoxazole Derivatives
2011-02-0320110028507126727852008-08-08PYRIDINE DERIVATIVES AND METHODS OF USE THEREOF
2011-02-0320110028508128102312009-01-09NOVEL PROCESS FOR THE PREPARATION OF SCOPINE ESTERS
2011-02-0320110028509129370742009-04-08Sulfonamides
2011-02-0320110028510127080762010-02-18Compositions, Methods, and Kits for Treating Influenza Viral Infections
2011-02-0320110028511128439082010-07-27PROCESS FOR THE MANUFACTURE OF PHARMACEUTICALLY ACTIVE COMPOUNDS
2011-02-0320110028512129007792010-10-08BIS-HETEROCYCLIC IMIDAZOLYL COMPOUNDS
2011-02-0320110028513129349882009-03-31METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
2011-02-0320110028514127725522010-05-03Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
2011-02-0320110028515128420622010-07-23NEW PIPERIDINE DERIVATIVES
2011-02-0320110028516129046752010-10-14STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS
2011-02-0320110028517129366982009-04-074-METHYL-4,5-DIHYDRO-1H-PYRAZOLE-3-CARBOXAMIDE USEFUL AS A CANNABINOID CB1 NEUTRAL ANTAGONIST
2011-02-0320110028518129218732009-03-18DEXLANSOPRAZOLE PROCESS AND POLYMORPHS
2011-02-0320110028519129017072010-10-11SMALL MOLECULE INSULIN MIMETICS ABSENT QUINONES
2011-02-0320110028520129355932009-04-021,5-DIPHENYL-PYRROLIDIN-2-ONE COMPOUNDS AS CB-1 LIGANDS
2011-02-0320110028522129210492009-03-03FULLERENE THERAPIES FOR INFLAMMATION
2011-02-0320110028523128284292010-07-01Selective Alpha 2B/2C Agonists
2011-02-0320110028524129021862010-10-12PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS
2011-02-0320110028526129191652009-02-27VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONS
2011-02-0320110028527128458682010-07-29Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma
2011-02-0320110028529127182082010-03-05NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471
2011-02-0320110028530127184272010-03-05NOVEL CRYSTALLINE FORMS OF 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID 471
2011-02-0320110028531127362302009-03-17NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801
2011-02-0320110028532128025272010-06-07Methods of treating eye diseases in diabetic patients
2011-02-0320110028533128664032009-02-05NOVEL FER -LIKE PROTEIN, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND METHOD FOR ITS USE
2011-02-0320110028534129010192010-10-08RNAi INHIBITION OF CTGF FOR TREATMENT OF OCULAR DISORDERS
2011-02-0320110028535129040542010-10-13OLIGONUCLEOTIDES-TRANSFERRING PREPARATIONS
2011-02-0320110028536123774982007-08-16METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
2011-02-0320110028537127270612010-03-18SOMATIC CELL REPROGRAMMING
2011-02-0320110028538128425692010-07-23METHODS AND COMPOSITIONS RELATED TO TR4 LIGAND
2011-02-0320110028539128073092010-04-09Biologically active taxane analogs and methods of treatment
2011-02-0320110028540128120672009-01-09SYNTHESIS OF MACROCYCLIC CANCER CHEMOTHERAPY AGENTS AND METHODS OF USE
2011-02-0320110028541129358592008-05-15LUBIPROSTONE CRYSTAL, THE USE AND THE METHOD FOR THE PREPARATION THEREOF
2011-02-0320110028542126024062008-05-06COMPOSITIONS FOR PREVENTION OR TREATMENT OF ANOREXIA-CACHEXIA SYNDROME AND USES THEREOF
2011-02-0320110028543126591242010-02-25Formulations and methods of using nitric oxide mimetics in cancer treatment
2011-02-0320110028544129049602010-10-14CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE
2011-02-0320110028547127422452008-05-27NOVEL USE OF CAPSIATE OR DIHYDROCAPSIDATE
2011-02-0320110028548129013062010-10-08BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW
2011-02-0320110028549125995782008-05-09USE OF A MONOTERPENE TO TREAT OR PREVENT STRESS
2011-02-0320110028551129880262009-04-15NOVEL PROCESS FOR THE PREPARATION OF SODIUM GAMMA-HYDROXYBUTYRATE
2011-02-0320110028552128230662010-06-24MEXILETINE AMINO ACID AND PEPTIDE PRODRUGS AND USES THEREOF
2011-02-0320110028553126464992009-12-23TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028554126001092008-05-16 PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE
2011-02-0320110028555128988252010-10-06Antiinflammatory and Analgesic Preparation for External Use
2011-02-0320110028556125709122009-09-30TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028557126995952010-02-03TREATING PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028558128309912010-07-06TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN
2011-02-0320110028559126679702008-06-20SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
2011-02-0320110028560128107582008-12-17SELF-EMULSIFIABLE LIQUID FLORFENICOL COMPOSITION INTENDED TO BE INCORPORATED INTO THE DRINKING WATER OF LIVESTOCK
2011-02-0320110028561128679312009-02-23PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM
2011-02-0320110028562128638812009-01-19DERIVATIVES OF AMINOALKANOLS, METHOD OF OBTAINING OF AMINOALKANOLS AND THEIR USE
2011-02-0320110028564127102032010-02-22COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
2011-02-0320110028565128868872010-09-21EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT
2011-02-0320110028566127791642010-05-13COMPOSITIONS AND PRODUCTS CONTAINING CYCLOALIPHATIC DIOL ANTIMICROBIAL AGENTS AND METHODS OF USING THE COMPOSITIONS AND PRODUCTS
2011-02-0320110028567129023652010-10-12SMOOTH MUSCLE CONTRACTION INHIBITORS
2011-02-0320110028568129185912009-02-18PREPARATION FOR MAGNESIUM AMMONIUM PHOSPHATE CEMENTS
2011-02-0320110028570125123012009-07-30SELF EMULSIFYING GRANULES AND PROCESS FOR THE PREPARATION OF EMULSIONS THEREFROM
2011-02-0320110028571126967652010-01-29SILICONE-MODIFIED WAX-CONTAINING COMPOSITION AND COSMETIC PREPARATION CONTAINING THE COMPOSITION
2011-02-0320110028589126780682008-09-12DENTAL POLYMERIZABLE COMPOSITION AND KIT THEREFOR
2011-02-0320110030073127455362008-11-28THERAPEUTIC TARGETS AND MEDICAMENTS INVOLVING P230/GOLGIN-245